Viewing Study NCT02744092


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-02-20 @ 5:57 PM
Study NCT ID: NCT02744092
Status: COMPLETED
Last Update Posted: 2023-10-03
First Post: 2016-04-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Sponsor: Alliance Foundation Trials, LLC.
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AFT-28
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View